Vifor Pharma

Vifor Pharma offers to fix alleged anti-competitive behaviour
Reuters
Fri, 04/19/24 - 11:24 am
Vifor Pharma
antitrust
anti-competitive scheme
CSL gets top-line boost thanks to a post-pandemic boom in plasma collections
Fierce Pharma
Wed, 08/16/23 - 11:14 pm
CSL
COVID-19
plasma
CSL Behring
Vifor Pharma
Days after buyout news, Vifor outlines plan to offload 'non-core' finished drug manufacturing wing
Endpoints
Thu, 12/16/21 - 11:53 pm
Vifor Pharma
CSL
M&A
Biopharma’s buyout year ends with a bang
EP Vantage
Wed, 12/15/21 - 10:37 am
M&A
CSL
Vifor Pharma
Pfizer
Arena Pharmaceuticals
As year-end deals start to sizzle, CSL moves a biotech buyout to the front burner with deal expected Tuesday — report
Endpoints
Mon, 12/13/21 - 11:02 am
M&A
Vifor Pharma
CSL
Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data
Fierce Biotech
Mon, 11/22/21 - 10:23 am
Spain
Sanifit
M&A
Vifor Pharma
Angion’s kidney transplant dream dies
EP Vantage
Wed, 10/27/21 - 10:52 am
Angion Biomedica
ANG-3777
kidney injury
Vifor Pharma
Vifor Licenses Rare Kidney Disease Drug in Comeback for Travere
BioSpace
Sat, 09/18/21 - 08:23 pm
Vifor Pharma
Travere Therapeutics
kidney disease
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai
BioSpace
Mon, 08/23/21 - 11:10 am
FDA
Cara Therapeutics
Vifor Pharma
Korsuva
Kadmon
belumosudil
Bristol Myers Squibb
Opdivo
Merck
Eisai
Keytruda
Vifor Pharma Group announces successful sale of OM Pharma
Pharmaceutical Business Review
Mon, 09/21/20 - 10:29 am
Vifor Pharma
OM Pharma
Optimus Holding
M&A
Vifor commits €25M to nephrology R&D joint venture with Evotec
Fierce Biotech
Wed, 11/6/19 - 10:30 am
Vifor Pharma
Evotec
renal therapy
nephrology